Information Journal Paper
APA:
Copy. (2020). Patients of COVID-19 may benefit from sustained Lopinavir-combined regimen and the increase of Eosinophil may predict the outcome of COVID-19 progression. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 95(-), 183-191. SID. https://sid.ir/paper/780845/en
Vancouver:
Copy. Patients of COVID-19 may benefit from sustained Lopinavir-combined regimen and the increase of Eosinophil may predict the outcome of COVID-19 progression. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES[Internet]. 2020;95(-):183-191. Available from: https://sid.ir/paper/780845/en
IEEE:
Copy, “Patients of COVID-19 may benefit from sustained Lopinavir-combined regimen and the increase of Eosinophil may predict the outcome of COVID-19 progression,” INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, vol. 95, no. -, pp. 183–191, 2020, [Online]. Available: https://sid.ir/paper/780845/en